Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients

T. J. Walsh, J. W. Hiemenz, E. Anaissie

Research output: Contribution to journalArticlepeer-review

Abstract

Patients who are receiving cytotoxic chemotherapy for neoplastic diseases, including those receiving allogeneic bone marrow transplantation, are predisposed to develop invasive fungal infections as the result of host defense impairments due to intensive cytotoxic chemotherapy, ablative radiation therapy, corticosteroids, cyclosporine, and the underlying neoplastic process. This article reviews the current approaches and problems in diagnosis, treatment, and prevention of invasive fungal infections in neutropenic patients.

Original languageEnglish (US)
Pages (from-to)365-400
Number of pages36
JournalInfectious disease clinics of North America
Volume10
Issue number2
DOIs
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients'. Together they form a unique fingerprint.

Cite this